AAAAAA
Results:
1-11
|
Results: 11
Authors:
ROSENTHAL MA
DENNIS D
LIEBES L
FURMANSKI P
CARON D
GARRISON L
WIPROVNICK J
PEACE D
ORATZ R
SPEYER J
CHACHOUA A
Citation: Ma. Rosenthal et al., BIOLOGIC ACTIVITY OF INTERLEUKIN-1 (IL-1)ALPHA IN PATIENTS WITH REFRACTORY MALIGNANCIES, Journal of immunotherapy, 21(5), 1998, pp. 371-378
Authors:
DARROW SL
SPEYER J
MARCUS AC
TERMAAT J
KROME D
Citation: Sl. Darrow et al., COPING WITH CANCER - THE IMPACT OF THE CANCER INFORMATION-SERVICE ON PATIENTS AND SIGNIFICANT OTHERS - PART 6, Journal of health communication, 3, 1998, pp. 86-96
Authors:
SPEYER J
WASSERHEIT C
Citation: J. Speyer et C. Wasserheit, STRATEGIES FOR REDUCTION OF ANTHRACYCLINE CARDIAC TOXICITY, Seminars in oncology, 25(5), 1998, pp. 525-537
Authors:
SPEYER J
Citation: J. Speyer, AMELIORATION OF CHEMOTHERAPY-INDUCED CARDIOTOXICITY - INTRODUCTION, Seminars in oncology, 25(4), 1998, pp. 1-2
Authors:
HOCHSTER H
LIEBES L
SPEYER J
SORICH J
TAUBES B
ORATZ R
WERNZ J
CHACHOUA A
BLUM RH
ZELENIUCHJACQUOTTE A
Citation: H. Hochster et al., EFFECT OF PROLONGED TOPOTECAN INFUSION ON TOPOISOMERASE-1 LEVELS - A PHASE-I AND PHARMACODYNAMIC STUDY, Clinical cancer research, 3(8), 1997, pp. 1245-1252
Authors:
HOCHSTER H
CHACHOUA A
SORICH J
WASSERHEIT C
TAUBES B
FRIEDBERG A
ARBUCK S
SPEYER J
Citation: H. Hochster et al., PHASE-I STUDY OF PACLITAXEL(P) COMBINED WITH 14-DAY TOPOTECAN(T) CONTINUOUS IV (CIV) INFUSION IN PREVIOUSLY TREATED AND UNTREATED PATIENTS (PTS), European journal of cancer, 33, 1997, pp. 1131-1131
Authors:
SWAIN SM
WHALEY FS
GERBER MC
WEISBERG S
YORK M
SPICER D
JONES SE
WADLER S
DESAI A
VOGEL C
SPEYER J
MITTELMAN A
REDDY S
PENDERGRASS K
VELEZGARCIA E
EWER MS
BIANCHINE JR
GAMS RA
Citation: Sm. Swain et al., CARDIOPROTECTION WITH DEXRAZOXANE FOR DOXORUBICIN-CONTAINING THERAPY IN ADVANCED BREAST-CANCER, Journal of clinical oncology, 15(4), 1997, pp. 1318-1332
Authors:
WASSERHEIT C
FRAZEIN A
ORATZ R
SORICH J
DOWNEY A
HOCHSTER H
CHACHOUA A
WERNZ J
ZELENIUCHJACQUOTTE A
BLUM R
SPEYER J
Citation: C. Wasserheit et al., PHASE-II TRIAL OF PACLITAXEL AND CISPLATIN IN WOMEN WITH ADVANCED BREAST-CANCER - AN ACTIVE REGIMEN WITH LIMITING NEUROTOXICITY, Journal of clinical oncology, 14(7), 1996, pp. 1993-1999
Authors:
MORGAN RJ
SPEYER J
DOROSHOW JH
MARGOLIN K
RASCHKO J
SORICH J
AKMAN S
LEONG L
SOMLO G
VASILEV S
AHN C
JOHNSON D
BELLER U
Citation: Rj. Morgan et al., MODULATION OF 5-FLUOROURACIL WITH HIGH-DOSE LEUCOVORIN CALCIUM - ACTIVITY IN OVARIAN-CANCER AND CORRELATION WITH CA-125 LEVELS, Gynecologic oncology, 58(1), 1995, pp. 79-85
Authors:
HOCHSTER H
LIEBES L
SPEYER J
SORICH J
TAUBES B
ORATZ R
WERNZ J
CHACHOUA A
RAPHAEL B
VINCI RZ
BLUM RH
Citation: H. Hochster et al., PHASE-I TRIAL OF LOW-DOSE CONTINUOUS TOPOTECAN INFUSION IN PATIENTS WITH CANCER - AN ACTIVE AND WELL-TOLERATED REGIMEN, Journal of clinical oncology, 12(3), 1994, pp. 553-559
Authors:
WADLER S
BEITLER JJ
RUBIN JS
HAYNES H
MCGILL F
ROZENBLIT A
GOLDBERG G
COHEN C
SPEYER J
RUNOWICZ C
Citation: S. Wadler et al., PILOT TRIAL OF CISPLATIN, RADIATION, AND WR2721 IN CARCINOMA OF THE UTERINE CERVIX - A NEW-YORK GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 11(8), 1993, pp. 1511-1516
Risultati:
1-11
|